Base Year
Historical Year
Forecast Year
The global assisted reproductive technology market was valued at USD 29.23 billion in 2023, driven by the increasing infertility rates and rising healthcare expenditure across the globe. The market size is anticipated to grow at a CAGR of 7.24% during the forecast period of 2024-2032 to achieve a value of USD 82.39 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing advancements in the field by key players are expected to drive the growth of the market in the coming years. The expanding applications of AI in assisted reproductive technology (ART) are expected to further propel the market demand. Advanced technologies, such as precision 3D printing and advanced microscopes, are expected to assist in identifying embryos and promoting healthy pregnancy, further propelling the global assisted reproduction technology market demand.
The rapidly advancing technology is enabling people to conceive even when they are having medical issues. Such advanced technologies are directly contributing to the increasing demand, further fuelling the market growth. A few examples of assisted reproductive technologies include In-vitro Fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT), among others.
A significant rise in the adoption of these advancing technologies for broader adoption with increasing awareness among healthcare professionals is expected to propel the market growth. The rising cases of infertility worldwide are leading to the increased adoption of assisted reproduction technology (ART), contributing significantly to the assisted reproductive technology market share. The high success rates of ART across the globe are gaining traction while providing hope to people who have some medical issues but look forward to conceiving in the coming future. The increasing disposable income among people mostly in developing countries is also contributing to the market growth.
Technological Advancements Bolstering the Market
The key players in the market are focusing on developing advanced healthcare systems to assist people in need of assisted reproduction technology, which is further expected to greatly influence the assisted reproduction technology market demand. Technologies like machine learning models are being introduced in the market to optimize hormonal treatments, including FSH (follicle-stimulating hormone) for better results. Other than that, various innovative platforms have been working on enabling remote monitoring and testing, various efforts are being made in electronic witnessing systems and robotic cryopreservation systems, which can help streamline the whole system of tracking and preserving eggs, sperms, and embryos. AI tools are one of the biggest developments in the healthcare sector, these tools are widely being used to enhance the fertility outcomes and make it more cost-effective.
For instance, in October 2022, Alife, after doing thorough research and development for over two years, introduced a new AI based software that can aid fertility clinics to improve fertility outcomes by optimizing and supporting the critical decisions during the process of IVF.
Rising Support from the Government to Support the Growth of the Assisted Reproductive Technology Market
The growth of the market is driven by the increasing initiatives by governments towards the regulation of practices as safe and effective for the people acquiring assistance from such services. For instance, In April 2023, the Ministry of Health and Family Welfare (MoHFW) rolled back the manner of retrieving oocytes and placing embryos vide assisted reproductive technology regulations in a manner where the health of the patient would not be compromised.
Additionally, In June 2023, the government of Beijing announced that they will cover 16 types of assisted reproduction technology under the city's health care system. This is an effort to boost China's declining birth rate. In-vitro fertilization, embryo transplantation, freezing, and storing semen are some of the treatments that will be included under basic insurance. This initiative by the government is expected to drive the market growth by encouraging people to have babies. The expenses of these services will be covered under health insurance, making it more convenient for people to avail of the services. This change is expected to increase the adaptation and demand for these services in the market during the forecast period. It could potentially lead to more people using these methods to have babies, which in turn could increase the number of births in Beijing.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
| Key Trends | Impact |
| Rising Prevalence of Infertility | The growth of the market is primarily driven by the rising prevalence of infertility and other reproductive issues across the world. Infertility affects millions of people every year, one in every six people of reproductive age, which is nearly 17.5% of the total adult population, is affected by infertility in their life. Assisted reproductive technologies have been in the market for over three decades and have intervened in the birth of more than 5 million children across the world. These technologies are still widely inaccessible because of the price point, which is unaffordable for majority of the population, especially in low-income countries. |
| Global Recognition by Regulatory Authorities | The market is witnessing surge in approvals from regulatory authorities to promote the innovative and new technologies in the market. In April 2023, TMRW Life Sciences, a fertility technology company automating the IVF lab, announced the receiving of CE Mark for the CryoRobot Select (CRS). The European designation follows clearance by the U.S. Food and Drug Administration, and the two regulatory achievements demonstrate that TMRW's automated platform for the safe management and storage of frozen eggs and embryos is now the global standard. TMRW’s recognition as a global standard is expected to increase the widespread adaptation of this technology to make the whole process safer and more standardized. |
| Strategic Acquisition Activities by Key Players | The rising competition amongst the key players is also aiding the assisted reproductive technology market growth. In July 2023, Baring Private Equity Asia (BPEA) EQT agreed to acquire a controlling stake in Indira IVF from TA Associates and the company’s founders. BPEA EQT is expected to acquire a 60% stake for USD 656.6 million. As India is one of the fastest-growing markets globally for assisted reproductive technology services, this acquisition is further anticipated to increase the market reach in more developed markets with this acquisition, driving the market growth. |
| Expanding Applications | Increased application of assisted reproductive technologies in emerging domains such as surrogacy is amongst major market trends. Traditionally, surrogacy used to rely on surrogate mother's egg for conception. However, currently, there is a preference for transferring embryos to the surrogate, either from the mother or donor. This is leading to adoption of assisted reproductive technologies across multiple domains. |
In March 2024, the Australian government announced a USD 42.3 million investment to launch multiple programs intended to boost fertility in the region. It is reported that 1 in 6 Australians are facing fertility associated challenges, pushing the demand for assisted reproductive technologies. Under the new investment plan, around USD 32.1 million is expected to offer subsidized reproductive assistance treatment while USD 10.2 million will be directed towards a statewide "fertility preservation service", educating people to make family planning decisions effectively. The initiative is also focused on providing affordable ART to both males and females.
In June 2023, FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package, enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization (IVF). Life Whisperer Genetics, when combined with Life Whisperer Viability, offers a distinctive way to help choose blastocysts during clinical processes. This combined platform helps identify blastocysts with a higher chance of being euploid and leading to successful pregnancies, all within a single system.
Market Breakup by Procedure
Market Breakup by Technology
Market Breakup by Product
Market Breakup by Age
Market Breakup by Application
Market Breakup by Region
Market Segmentation Based on Technique is Anticipated to Witness Substantial Growth
Based on technique, the market is segmented into in vitro-fertilization, artificial insemination, and others. In-vitro fertilization is expected to hold a substantial market share in the forecast period. The market value for this segment can be attributed to high success rates, advantages such as preimplantation genetic testing (PGT), allowing embryo screening for genetic disorders. Artificial insemination is likely to gain significant growth, owing to its less invasive nature and a simpler process as compared to in-vitro fertilization.
Application Areas to Experience Notable Growth in Forecast Period
The market segmentation based on application includes frozen embryo replacement (FER), surrogacy, ovulation induction, and others. These application address different aspects and needs of patients, catering to specific medical conditions and history of a patient. Frozen embryo replacement (FER) includes embryo freezing, thawing, and transferring to a uterus. With minimal physical and emotional burden, it helps in higher success rate, convenience, and improved outcomes for patients. Surrogacy has also emerged as a functional application area, with shifts from traditional methods (where the mother was artificially inseminated) to gestational surrogacies, which facilitate gamete implantation with no genetic connection. In addition, ovulation induction requires assisted reproductive technologies, as it includes the use of medicines to stimulate ovaries for egg production and release.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America has been leading the global market for assisted reproductive technology and it is likely to continue dominating the market in the forecast period. The region is anticipated to dominate in the forecast period due to the robust healthcare infrastructure and decreasing fertility, increasing research activities. The region is likely to continue dominating the global market owing to the presence of renowned clinics in the region.
In October 2023, Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies ("ART") research and cell biology markets, announced that they have acquired Gynetics Medical Products, N.V., and Gynetics Services B.V. (collectively, "Gynetics"). Gynetics, based in Lommel, Belgium is a leading manufacturer of a wide range of innovative, high-quality In Vitro Fertilization ("IVF") devices in the global IVF market. The acquisition is poised to highlight Hamilton Thorne's consumables product offerings and increase the market reach for profitable operations in the well-established European ART market.
The key features of the market report comprise patent analysis, clinical trial analysis, and strategic initiatives by the leading players including mergers and collaborations and new product launches. The major companies in the market are as follows:
California Cryobank
California Cryobank based out of United States, has a significant market presence. It offers multiple services and programs leveraging assisted reproductive technology. Major services include donor semen programs, genetic services and CCB family services, among others.
Merck KGaA
Headquartered in Germany, Merck KGaA, with key areas of attention such as ovarian stimulation, luteal phase support, embryo culture and handling, cryopreservation along with diagnostic tools. It is a pioneer in research and focuses on developing novel therapeutic approaches.
FUJIFILM Irvine Scientific
California-based, FUJIFILM Irvine Scientific was established in 1970. It is known for high quality IVF culture media, offering a nurturing environment to embryos. Moreover, the company is constantly expanding its services focused on personalised medicine approaches, and methods to improve implantation rates.
Nikon Corporation
Established in 1917, it is a well-known organisation with expertise in imaging equipment and provides high-quality microscopes and imaging systems vital for several ART procedures. The company is focusing on integrating AI and digital technologies to offer accurate diagnosis of embryo and gametes.
Other key players in the market include Bloom Fertility Centre, Anecova, CooperSurgical, Ferring B.V., Genea Pty Ltd., Nidacon International AB, Celmatix Inc., Microm U.K. Ltd., Cryolab Ltd., and Vitrolife AB.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Procedure |
|
| Breakup by Technology |
|
| Breakup by Product |
|
| Breakup by Age |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share